Corbus Pharmaceuticals Holdings, Inc.
CRBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595097
In the last 90 days, Corbus Pharmaceuticals Holdings, Inc. insiders filed 1 open-market purchase and 3 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $129.1M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Corbus Pharmaceuticals Holdings, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 30 | 28 | −2 |
| Shares | 723.8K | 739.4K | +15.6K (+2.2%) |
| Value | $5.26M | $5.80M | +$536.7K (+10.2%) |
New holders (2)
Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Dorsey Wright & Associates | 2,555 | $20.0K | 0.01% |
| Royal Bank of Canada | 1,512 | $12.0K | 0.00% |
Sold out (4)
Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Virtu Financial LLC | 10,077 | $73.0K |
| Cutler Group LP | 353 | $2.00K |
| Accel Wealth Management | 46 | $334 |
| Belpointe Asset Management LLC | 22 | $160 |